CXCL4 in atherosclerosis: Possible roles in monocyte arrest and macrophage foam cell formation

Christian A. Gleissner; Klaus Ley

doi:10.1160/TH07-09-0567

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 98(05): 917-918
DOI: 10.1160/TH07-09-0567

Editorial Focus

Schattauer GmbH

CXCL4 in atherosclerosis: Possible roles in monocyte arrest and macrophage foam cell formation

Christian A. Gleissner^*

¹Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA

³Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA

,

Klaus Ley^*

¹Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA

²Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA

³Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA

› Author Affiliations

Abstract

Full Text

References

References
1 Sachais BS, Turrentine T, Dawicki McKenna JM. et al. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in c57bl/6 and apoE-/- mice. Thromb Haemost 2007; 98: 1108-1113.
2 Deuel TF, Keim PS, Farmer M. et al. Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci USA 1977; 74: 2256-2258.
3 Massberg S, Schulz C, Gawaz M. Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med 2003; 3: 147-162.
4 Huo Y, Schober A, Forlow SB. et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67.
5 von Hundelshausen P, Weber KS, Huo Y. et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 1772-1777.
6 Pitsilos S, Hunt J, Mohler ER. et al. Platelet factor 4 localization in carotid atherosclerotic plaques: Correlation with clinical parameters. Thromb Haemost 2003; 90: 1112-1120.
7 von Hundelshausen P, Petersen F, Brandt E. Platelet- derived chemokines in vascular biology. Thromb Haemost 2007; 97: 704-713.
8 Ley K, Laudanna C, Cybulsky MI. et al. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689.
9 von Hundelshausen P, Koenen RR, Sack M. et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005; 105: 924-930.
10 Scheuerer B, Ernst M, Durrbaum-Landmann I. et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 2000; 95: 1158-1166.
11 Cho HJ, Shashkin P, Gleissner CA. et al. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics 2007; 29: 149-160.
12 Smith J, Trogan E, Ginsberg M. et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 1995; 92: 8264-8268.
13 Pervushina O, Scheuerer B, Reiling N. et al. Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of gi protein activation or intracellular calcium transients. J Immunol 2004; 173: 2060-2067.
14 Sachais BS, Kuo A, Nassar T, et al. Higazi AA. Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. Blood 2002; 99: 3613-3622.
15 Nassar T, Sachais BS, Akkawi S. et al. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 2003; 278: 6187-6193.
16 Lasagni L, Francalanci M, Annunziato F. et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, mig, and I-tac, and acts as functional receptor for platelet factor 4. J Exp Med 2003; 197: 1537-1549.
17 Petersen F, Bock L, Flad HD. et al. A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. J Immunol 1998; 161: 4347-4355.